Company Filing History:
10 out of 75 
3 out of 17 
2 out of 5 Years Active: 2005-2013
Title: **The Innovative Journey of Inventor Michael Weske**
Introduction
Michael Weske is a prolific inventor based in Burgdorf, Germany, known for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 15 patents, Weske has made substantial advancements in the field of medicinal chemistry, focusing on compounds that target various steroid hormone-dependent diseases.
Latest Patents
Among his latest innovations are the 17-beta HSD1 and STS inhibitors, which involve substituted steroid compounds that act as selective inhibitors of 17β-hydroxysteroid dehydrogenase type I (17β-HSD1). These compounds may also inhibit steroid sulfatase and are accompanied by pharmaceutical preparations for their use. Weske's work demonstrates therapeutic methods to treat, inhibit, and prevent steroid hormone-dependent disorders, including those that necessitate reduced levels of endogenous 17β-estradiol.
Another notable patent involves screening and treatment methods using IGS5 enzymes from the metalloprotease family. This innovation focuses on polypeptides related to the neprilysin enzyme family, exhibiting zinc metalloprotease activities. It details methods for producing these polypeptides and their application in therapies for metabolic diseases such as type II diabetes, cardiovascular issues, and neurodegenerative disorders like Parkinson's Disease.
Career Highlights
Michael Weske's career includes significant tenures at renowned pharmaceutical companies, including Solvay Pharmaceuticals and Abbott Products. His expertise and innovative spirit have contributed to advancements that could reshape medical treatment protocols in multiple therapeutic areas.
Collaborations
Throughout his career, Weske has collaborated with various experts, including colleagues Dieter Ziegler and Yvan Fischer. These collaborations have enriched his work, leading to the development of cutting-edge technologies and treatments in the pharmaceutical industry.
Conclusion
Michael Weske's inventive prowess has positioned him as a key figure in the realm of medicinal innovations. With his ongoing research and development efforts, he continues to pave the way for novel therapeutic solutions that address pressing health challenges. His contributions not only highlight the importance of innovation in medicine but also reflect a broader commitment to enhancing patient care through science.